Ariel Feldstein
Director/Board Member at Elgia Therapeutics, Inc.
Network origin in Ariel Feldstein first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Elgia Therapeutics, Inc.
 Elgia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elgia Therapeutics, Inc. engages in the provision of pharmaceutical services. The company was founded in 2019 and is headquartered in San Diego, CA.
3
| Private Company | Pharmaceuticals: Major | 3 |
Jecure Therapeutics, Inc.
 Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ariel Feldstein via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of California, Berkeley | College/University | Undergraduate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor | |
| Stanford University School of Medicine | College/University | Doctorate Degree | |
Logos Capital Fund LLP
 Logos Capital Fund LLP Investment Trusts/Mutual FundsMiscellaneous Logos Capital Fund LLP functions as pooled investment fund. The company is headquartered in Rehoboth, DE. | Investment Trusts/Mutual Funds | Founder | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Pharmaceuticals: Major | Director/Board Member | |
| ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Director/Board Member | |
| CONTINEUM THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Logos Global Management LP
 Logos Global Management LP Investment ManagersFinance Logos Global Management LP (Logos) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Arsani William and Graham Walmsley in 2019. They are owned and controlled by Logos Global Management GP LLC. Logos provides discretionary investment management services to privately offered pooled investment vehicles. | Investment Managers | Founder | |
| SCIENCE 37 HOLDINGS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
Mediar Therapeutics, Inc.
 Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| The Pennsylvania State University | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Graduate Degree | |
| University of California, Irvine | College/University | Doctorate Degree |
Statistics
International
| United States | 17 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 6 |
| Finance | 4 |
| Miscellaneous | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 9 |
| Corporate Officer/Principal | 4 |
| Independent Dir/Board Member | 4 |
| Founder | 3 |
| Undergraduate Degree | 2 |
Most connected contacts
| Insiders | |
|---|---|
| Graham Walmsley | 13 |
| Stacie Canan | 4 |
| Brian Hubbard | 2 |
| Alan Saltiel | 1 |
- Stock Market
- Insiders
- Ariel Feldstein
- Company connections
